|

Propranolol Clinical Trials

8 actively recruiting trials across 4 locations

Also known as: 1-[(1-Methylethyl)amino]-3-(1-naphthalenyloxy)-2-propanol, Betablocker, Inderal, Propal

Other4 trials

Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
Phase 2
Examining Safety, Efficacy and Feasibility of Preoperative Propranolol in Patients With PDAC.
Phase 2
Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients
Phase 2
Propranolol and Von Hippel-Lindau Disease
N/A

Chandler, Arizona1 trial

Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib

Ironwood Cancer and Research Center

Phase 2

Basking Ridge, New Jersey1 trial

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)

N/A

New Brunswick, New Jersey1 trial

Naltrexone and Propranolol Combined With Immunotherapy

Rutgers Cancer Institute of New Jersey

Phase 1

Buffalo, New York1 trial

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

Roswell Park Cancer Institute

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.